SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases. With over 30 years of experience, it emphasizes research-driven therapies and strategic partnerships to transform patient care. The company is headquartered in Rockville, Maryland, and maintains a portfolio of CNS products including recently approved therapies. Its science and product pipeline aim to address unmet medical needs in neurology and psychiatry across multiple patient populations.
No recent deals for this company.